Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-054024

Chief Financial Officer sold 1,697 shares at $6.03 ($10,233)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2023-10-30 Sale −1,697 $6.03 $10,233 144,145 D
Open-market sales · 1,697 sh · avg $6.03 · $10,233
Loading xslF345X05/doc4.xml…